LeadIQ logo
Learn more at LeadIQ.com

Insights

Investor Engagement Kyntra Bio is actively engaging investors and presenting at major conferences (H.C. Wainwright Global Investment Conference, Needham Healthcare Conference) signaling a growth narrative and funding readiness that sales teams can leverage for partnerships, co-development deals, or strategic collaborations.

Financial Momentum Recent quarterly improvement with positive income from continuing operations and a significant revenue base positions the company as a credible partner with appetite for scalable collaborations, licensing opportunities, and expanded commercial activities.

Clinical Progress Data releases from the MATTERHORN Phase 3 program and transfusion independence outcomes in LR-MDS suggest ongoing progression and unmet medical needs, creating ample opening for companion diagnostics, ancillary tests, or enrollment partnerships.

Global Presence Participation in European and U.S. healthcare and investor events indicates an intent to broaden market reach, creating sales opportunities across geographies for clinical services, manufacturing partnerships, or regional commercialization agreements.

Tech & Infrastructure Adoption of cloud, analytics, and modern CMS tools (Google Cloud, Sentry, Piwik PRO) points to a data-driven operation; this affords opportunities for AI-enabled research services, data analytics collaborations, and compliant data management partnerships.

Similar companies to FibroGen, Inc.

FibroGen, Inc. Tech Stack

FibroGen, Inc. uses 8 technology products and services including iCIMS, WordPress, Wix eCommerce, and more. Explore FibroGen, Inc.'s tech stack below.

Media & News

FibroGen, Inc.'s Email Address Formats

FibroGen, Inc. uses at least 5 email formats:
FibroGen, Inc. Email FormatsExamplePercentage
FLast@fibrogen.comJDoe@fibrogen.com
87%
FirstLast@fibrogen.comJohnDoe@fibrogen.com
8%
FiLast@fibrogen.comJoDoe@fibrogen.com
3%
FirLast@fibrogen.comJohDoe@fibrogen.com
2%
FLast@kyntrabio.comJDoe@kyntrabio.com
100%

Frequently Asked Questions

What is FibroGen, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact FibroGen, Inc.'s main corporate office by phone at
+1-415-978-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is FibroGen, Inc.'s stock symbol?

Minus sign iconPlus sign iconFibroGen, Inc. is a publicly traded company; the company's stock symbol is AMGN.

What is FibroGen, Inc.'s official website and social media links?

Minus sign iconPlus sign iconFibroGen, Inc.'s official website is kyntrabio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does FibroGen, Inc. generate?

Minus sign iconPlus sign icon As of October 2026, FibroGen, Inc.'s annual revenue is estimated to be $1M - $10M.

What is FibroGen, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign iconFibroGen, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does FibroGen, Inc. have currently?

Minus sign iconPlus sign iconAs of October 2026, FibroGen, Inc. has approximately 272 employees across 4 continents, including North America, Asia and Europe. Key team members include Chief Executive Officer: T. N., Ceo: J. K. and Chief Intellectual: L. P. Explore FibroGen, Inc.'s employee directory with LeadIQ.

What industry does FibroGen, Inc. belong to?

Minus sign iconPlus sign iconFibroGen, Inc. operates in the Biotechnology Research industry.

What technology does FibroGen, Inc. use?

Minus sign iconPlus sign iconFibroGen, Inc.'s tech stack includes iCIMS, WordPress, Wix eCommerce, Microsoft 365, Google Cloud, Sentry, WP Engine and Piwik PRO Core.

What is FibroGen, Inc.'s email format?

Minus sign iconPlus sign iconFibroGen, Inc.'s email format typically follows the pattern of FLast@fibrogen.com. Find more FibroGen, Inc. email formats with LeadIQ.

How much funding has FibroGen, Inc. raised to date?

Minus sign iconPlus sign icon As of October 2026, FibroGen, Inc. has raised $358M in funding. The last funding round occurred on May 01, 2023.

When was FibroGen, Inc. founded?

Minus sign iconPlus sign iconFibroGen, Inc. was founded in 1993.
FibroGen, Inc. logo

FibroGen, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

FibroGen, Inc. is a biotechnology research company based in San Francisco, California, with a workforce that reflects a mid-sized enterprise. The organization is transitioning to the name Kyntra Bio, signaling a sharpened direction grounded in rigorous science and the prospect of substantial impact. This branding shift accompanies its evolving strategic emphasis within the biotechnology field.

Recent developments include data from the Phase 3 MATTERHORN trial showing improvements in transfusion independence for patients with anemia linked to lower-risk myelodysplastic syndromes treated with roxadustat, to be presented as a poster at the European Hematology Association Congress 2026 in Stockholm. The announcement situates the company within hematology and biotech research as it shares late-stage clinical results.

Section iconCompany Overview

Phone number
+1-415-978-****
Website
kyntrabio.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
AMGN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1993
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $358M

    FibroGen, Inc. has raised a total of $358M of funding over 9 rounds. Their latest funding round was raised on May 01, 2023 as a Post IPO Debt.

  • $1M - $10M

    FibroGen, Inc.'s revenue is estimated to be in the range of $1M - $10M

Company Leadership

  • Chief Executive Officer at FibroGen, Inc.
    T. N.
    Chief Executive Officer
    Mobile Phone
  • Ceo at FibroGen, Inc.
    J. K.
    Ceo
    Mobile Phone
  • Chief Intellectual at FibroGen, Inc.
    L. P.
    Chief Intellectual
    Mobile Phone
  • Vice President , Business Development at FibroGen, Inc.
    M. T.
    Vice President , Business Development
    Mobile Phone
  • President at FibroGen, Inc.
    L. G.
    President
    Mobile Phone

Employee Directory

  • Head Of Translational Medicine, Clin Pharm And Bioanalytical at FibroGen, Inc.
    K. K.
    Head Of Translational Medicine, Clin Pharm And Bioanalytical
    Mobile Phone
  • Vice President, Manufacturing And Supply Operations at FibroGen, Inc.
    M. L.
    Vice President, Manufacturing And Supply Operations
    Mobile Phone
  • Head Of Sourcing And Procurement at FibroGen, Inc.
    S. D.
    Head Of Sourcing And Procurement
    Mobile Phone
  • Svp, China Operations at FibroGen, Inc.
    C. C.
    Svp, China Operations
    Mobile Phone
  • Chief Intellectual at FibroGen, Inc.
    L. P.
    Chief Intellectual
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.